Idacio
These highlights do not include all the information needed to use IDACIO safely and effectively. See full prescribing information for IDACIO. IDACIO® (adalimumab-aacf) injection, for subcutaneous use Initial U.S. Approval: 2022 IDACIO® (adalimumab-aacf) is biosimilar to HUMIRA® (adalimumab).
43de75ac-1a37-4609-9edd-68bda2448a47
HUMAN PRESCRIPTION DRUG LABEL
Mar 22, 2023
Fresenius Kabi USA, LLC
DUNS: 013547657
Products 2
Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.
adalimumab
Product Details
FDA regulatory identification and product classification information
FDA Identifiers
Product Classification
Product Specifications
INGREDIENTS (7)
adalimumab
Product Details
FDA regulatory identification and product classification information